SCHEMBL21648456

SCHEMBL21648456

Bc1cc2oc3ccc4ccccc4c3c2c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 5/20 0.44
▸ AHR P35869 4/20 0.44
▸ PAX8 Q06710 2/20 0.44
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ FYN P06241 1/20 0.44
▸ MAPK3 P27361 1/20 0.44
▸ TDP1 Q9NUW8 3/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ MAPT P10636 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HNF4A P41235 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30091394 0.82 TDP1 (0.55) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL415466 0.82 TDP1 (0.55) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL16548075 0.80 TDP1 (0.46) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL18201535 0.79 MAOA (0.43) AHRTDP1L3MBTL1MAPTNPC1
SCHEMBL13286516 0.79 HSD17B10 (0.46) AHRPAX8CYP1A2FYNTDP1
SCHEMBL24156128 0.79 AHR (0.46) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL10109874 0.79 HNF4A (0.50) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19080429 0.79 AHR (0.44) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL23592241 0.76 AHR (0.43) AHRCYP1A2MAPTNPC1RAB9A
SCHEMBL24028982 0.76 AHR (0.42) ABCG2AHRPAX8CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020022751-A1 ORGANIC ELECTROLUMINESCENT DEVICE 머티어리얼사이언스 주식회사 2020-01-30 — — WO disclosed
Send feedback